The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.
GlaxoSmithKline had established the range, but it was later transferred to Omega Pharma when the company sold off its portfolio of non-prescription drugs in 2012.